Galsulfase News
Galsulfase currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Galsulfase with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Naglazyme is indicated for long-term enzyme-replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis VI (MPS VI; N-acetylgalactosamine-4-sulfatase deficiency;...
- Evidence level: L5
- Predicted indications (20):
- ptosis-strabismus-ectopic pupils syndrome (97.9%)
- camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye (97.9%)
- congenital Horner syndrome (disease) (97.8%)
- ptosis-vocal cord paralysis syndrome (97.8%)
- ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome (97.7%)
- jaw-winking syndrome (97.7%)
- congenital entropion (97.6%)
- epiblepharon (97.5%)
- congenital ectropion (97.5%)
- mucopolysaccharidosis (96.9%)
- Scheie syndrome (94.8%)
- Steel syndrome (93.9%)
- inborn disorder of lysosomal amino acid transport (92.4%)
- proximal myopathy with extrapyramidal signs (91.3%)
- Hurler syndrome (90.2%)
- Charcot-Marie-Tooth disease (90.0%)
- Sanfilippo syndrome (88.7%)
- lysosomal storage disease with skeletal involvement (88.0%)
- alpha-mannosidosis (87.2%)
- skeletal muscle disease (86.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.